Startup using Gates-funded research to develop herpes & HIV vaccines, raising $12M
An Oregon immunotherapy startup says it’s developing a vaccine platform that stimulates the immune response around the clock – potentially guarding it perpetually against diseases like herpes, HPV and HIV. Tomegavax is building on the work of Oregon Health & Science University researcher Louis Picker, who recently received $30 million in funding from the Bill & […]